Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCDA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for BioCardia, Inc. as stock downgraded to Hold/Accumulate.
(Updated on May 16, 2024)

Buy or Hold candidate since May 06, 2024 Gain 2.48% PDF

The BioCardia, Inc. stock price fell by -0.95% on the last day (Thursday, 16th May 2024) from $0.400 to $0.396. During the last trading day the stock fluctuated 3.51% from a day low at $0.396 to a day high of $0.410. The price has risen in 6 of the last 10 days and is up by 5.63% over the past 2 weeks. Volume has increased on the last day by 65 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 155 thousand shares were bought and sold for approximately $61.56 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.12% during the next 3 months and, with a 90% probability hold a price between $0.282 and $0.426 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCDA Signals & Forecast

The BioCardia, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.396. On a fall, the stock will find some support from the long-term average at approximately $0.385. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 10.03%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. BioCardia, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for BioCardia, Inc. stock

BioCardia, Inc. finds support from accumulated volume at $0.389 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0139 between high and low, or 3.51%. For the last week, the stock has had daily average volatility of 3.70%.

Our recommended stop-loss: $0.378 (-4.56%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 19 days ago.)

Trading Expectations (BCDA) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect BioCardia, Inc. to open at $0.401, and during the day (based on 14 day Average True Range), to move between $0.377 and $0.415, which gives a possible trading interval of +/-$0.0188 (+/-4.76%) up or down from last closing price. If BioCardia, Inc. takes out the full calculated possible swing range there will be an estimated 9.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.400 (0.98%) than the support at $0.389 (1.69%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioCardia, Inc. stock A Buy?

BioCardia, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.470 Hold/Accumulate Downgraded

Predicted Opening Price for BioCardia, Inc. of Friday, May 17, 2024

Fair opening price May 17, 2024 Current price
$0.401 ( 1.17%) $0.396

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCDA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.415 4.68 %
R2 0.409 3.34 %
R1 0.406 2.51 %
Current price: 0.396
Support S1 0.395 -0.171 %
S2 0.392 -1.00 %
S3 0.387 -2.34 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.455 14.90 %
R2 0.444 11.97 %
R1 0.400 0.98 %
Current price 0.396
Support S1 0.389 -1.69%
S2 0.382 -3.69%
S3 0.376 -5.02%

FAQ

What is the symbol for BioCardia, Inc. Stock and on which exchange is it traded?
The symbol for BioCardia, Inc. is BCDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioCardia, Inc. Stock?
BioCardia, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy BioCardia, Inc. Stock?
BioCardia, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioCardia, Inc. Stock.

What's the current price of BioCardia, Inc. Stock?
As of the end of day on the May 16, 2024, the price of an BioCardia, Inc. (BCDA) share was $0.396.

What is the 52-week high and low for BioCardia, Inc. Stock?
The 52-week high for BioCardia, Inc. Stock is $2.92 and the 52-week low is $0.346.

What is the market capitalization of BioCardia, Inc. Stock?
As of the May 16, 2024, the market capitalization of BioCardia, Inc. is 10.744M.

When is the next earnings date for BioCardia, Inc.?
The upcoming earnings date for BioCardia, Inc. is Aug 14, 2024.
Click to get the best stock tips daily for free!

About BioCardia, Inc.

BioCardia. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture... BCDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT